Special Issue "Diagnostic and Therapeutic Challenges in Pancreatobiliary Diseases"

A special issue of Gastroenterology Insights (ISSN 2036-7422). This special issue belongs to the section "Pancreas".

Deadline for manuscript submissions: closed (30 September 2021).

Special Issue Editors

Dr. Raymond Tang
E-Mail Website
Guest Editor
Institute of Digestive Disease, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong
Interests: pancreatobiliary diseases; endoscopic ultrasound; ERCP; colorectal cancer screening
Dr. Rashid N. Lui
E-Mail Website
Guest Editor
Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong
Interests: young-onset colorectal cancer; fecal microbiota transplantation; digestive oncology

Special Issue Information

Dear Colleagues,

Clinical management of pancreatobiliary diseases can be challenging since symptoms and signs of various benign and malignant conditions of the pancreatobiliary system may overlap. Accurate diagnosis of the underlying pathology would help to guide subsequent clinical management, but differentiation between benign and malignant pathologies of the pancreatobiliary system may not always be straightforward. In patients with suspected pancreatobiliary diseases, prompt evaluation by blood tests, cross-sectional imaging and endoscopy (eg, EUS, ERCP) tailored to the presenting symptoms and signs would often help to clarify the diagnosis and triage appropriate treatment.

Despite advances in technology, diagnostic dilemma and therapeutic challenges are not uncommon in patients with benign and malignant pancreatobiliary diseases. Because a multi-disciplinary approach is often necessary to optimize care of these patients, this Special Issue is devoted to publication of review articles and original research to highlight the latest developments in the field of endoscopy, surgery, and oncology in patients with difficult to manage pancreatobiliary conditions.

Dr. Raymond Tang
Dr. Rashid N. Lui
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Gastroenterology Insights is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • indeterminate biliary strictures
  • cholangiocarcinoma
  • pancreatic cancer
  • ERCP
  • cholangioscopy
  • EUS

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

Review
The Role of EUS-Guided Drainage in the Management of Postoperative Fluid Collections after Pancreatobiliary Surgery
Gastroenterol. Insights 2021, 12(4), 433-442; https://0-doi-org.brum.beds.ac.uk/10.3390/gastroent12040041 - 05 Nov 2021
Viewed by 489
Abstract
Postoperative fluid collection (POFC) is a challenging complication following pancreatobiliary surgery. Traditional treatment with surgical drainage is associated with significant morbidity, while percutaneous drainage is associated with a higher rate of recurrence and the need for repeated interventions. Studies have shown that endoscopic [...] Read more.
Postoperative fluid collection (POFC) is a challenging complication following pancreatobiliary surgery. Traditional treatment with surgical drainage is associated with significant morbidity, while percutaneous drainage is associated with a higher rate of recurrence and the need for repeated interventions. Studies have shown that endoscopic ultrasound (EUS)-guided drainage may offer a promising solution to this problem. There are limited data on the ideal therapeutic protocol for EUS-guided drainage of POFC including the timing for drainage; type, size, and number of stents to use; and the need for endoscopic debridement and irrigation. Current practices extrapolated from the treatment of pancreatic pseudocysts and walled-off necrosis may not be applicable to POFC. There are increasing data to suggest that drainage procedures may be performed within two weeks after surgery. While most authors advocate the use of double pigtail plastic stents (DPPSs), there have been a number of reports on the use of novel lumen-apposing metal stents (LAMSs), although no direct comparisons have been made between the two. Full article
(This article belongs to the Special Issue Diagnostic and Therapeutic Challenges in Pancreatobiliary Diseases)
Review
Troubleshooting Difficult Bile Duct Access: Advanced ERCP Cannulation Techniques, Percutaneous Biliary Drainage, or EUS-Guided Rendezvous Technique?
Gastroenterol. Insights 2021, 12(4), 405-422; https://0-doi-org.brum.beds.ac.uk/10.3390/gastroent12040039 - 27 Oct 2021
Viewed by 730
Abstract
Despite experienced hands and availability of various well-designed catheters and wires, selective bile duct cannulation may still fail in 10–20% of cases during endoscopic retrograde cholangiopancreatography (ERCP). In case standard ERCP cannulation technique fails, salvage options include advanced ERCP cannulation techniques such as [...] Read more.
Despite experienced hands and availability of various well-designed catheters and wires, selective bile duct cannulation may still fail in 10–20% of cases during endoscopic retrograde cholangiopancreatography (ERCP). In case standard ERCP cannulation technique fails, salvage options include advanced ERCP cannulation techniques such as double-guidewire technique (DGW) with or without pancreatic stenting and precut papillotomy, percutaneous biliary drainage (PBD), and endoscopic ultrasound-guided Rendezvous (EUS-RV) ERCP. If the pancreatic duct is inadvertently entered during cannulation attempts, DGW technique is a reasonable next step, which can be followed by pancreatic stenting to reduce risks of post-ERCP pancreatitis (PEP). Studies suggest that early precut papillotomy is not associated with a higher risk of PEP, while needle-knife fistulotomy is the preferred method. For patients with critical clinical condition who may not be fit for endoscopy, surgically altered anatomy in which endoscopic biliary drainage is not feasible, and non-communicating multisegmental biliary obstruction, PBD has a unique role to provide successful biliary drainage efficiently in this particular population. As endoscopic ultrasound (EUS)-guided biliary drainage techniques advance, EUS-RV ERCP has been increasingly employed to guide bile duct access and cannulation with satisfactory clinical outcomes and is especially valuable for benign pathology at centres where expertise is available. Endoscopists should become familiar with each technique’s advantages and limitations before deciding the most appropriate treatment that is tailored to patient’s anatomy and clinical needs. Full article
(This article belongs to the Special Issue Diagnostic and Therapeutic Challenges in Pancreatobiliary Diseases)
Show Figures

Figure 1

Review
Neuropathic Pain in Pancreatic Cancer: An Update of the Last Five Years
Gastroenterol. Insights 2021, 12(3), 302-309; https://0-doi-org.brum.beds.ac.uk/10.3390/gastroent12030027 - 25 Jun 2021
Cited by 1 | Viewed by 1000
Abstract
Pain is the main symptom of pancreatic cancer (pancreatic ductal adenocarcinoma, PDAC). Pain in pancreatic cancer may be visceral, somatic or neuropathic in origin. Pain is produced by tissue damage, inflammation, ductal obstruction and infiltration. Visceral nociceptive signals caused by damage to the [...] Read more.
Pain is the main symptom of pancreatic cancer (pancreatic ductal adenocarcinoma, PDAC). Pain in pancreatic cancer may be visceral, somatic or neuropathic in origin. Pain is produced by tissue damage, inflammation, ductal obstruction and infiltration. Visceral nociceptive signals caused by damage to the upper abdominal viscera are carried along sympathetic fibers, which travel to the celiac plexus nerves and ganglia, which are found at the T12-L2 vertebral levels, anterolateral to the aorta near the celiac trunk. From here, the signals are transmitted through the splanchnic nerves to the T5-T12 dorsal root ganglia and then on to the higher centers of the central nervous system. Somatic and neuropathic pain may arise from tumor extension into the surrounding peritoneum, retroperitoneum and bones and, in the latter case, into the nerves, such as the lumbosacral plexus. It should also be noted that other types of pain might arise because of therapeutic interventions, such as post-chemoradiation syndromes, which cause mucositis and enteritis. Management with non-steroidal anti-inflammatory agents and narcotics was the mainstay of therapy. In recent years, celiac plexus blocks and neurolysis, as well as intrathecal therapies have been used to control severe pain, at times resulting in a decreased need for drugs, avoiding their unwanted side effects. Pain may impair the patient’s quality of life, negatively affecting patient outcome and resulting in increased psychological stress. Even after recognizing the negative effect of cancer pain on patient overall health, studies have shown that cancer pain is still undertreated. This review focuses on neuropathic pain, which is difficult to handle; thus, the most recent literature was reviewed in order to diagnose neuropathic pain and its management. Full article
(This article belongs to the Special Issue Diagnostic and Therapeutic Challenges in Pancreatobiliary Diseases)
Show Figures

Figure 1

Back to TopTop